You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Cross-tissue meta-analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease
Tiago C. Silva, Juan I. Young, Lanyu Zhang, Lissette Gomez, Michael A. Schmidt, Achintya Varma, Xi Chen, Eden R. Martin, Lily Wang
Citing this repository
Description
This github repository includes scripts used for the analyses in the above manuscript.
In this work, we performed a meta-analysis of two large independent blood-based epigenome-wide association studies, the ADNI and AIBL studies, and identified 5 CpGs mapped to the SPIDR, CDH6 genes, and intergenic regions that were significantly associated with AD diagnosis. Furthermore, to identify blood-based DNA methylation markers that also change with underlying neuropathology in the brain, we next performed a cross-tissue meta-analysis by combining these blood DNA methylation datasets with four additional DNA methylation datasets, which included a total of 1030 brain prefrontal cortex samples. Our findings provide a useful resource for future biomarker studies in AD.
1. Study cohorts, Preprocessing of DNA methylation data, Single Cohort analysis
versionRversion4.1.0 (2021-05-18)
osmacOSBigSur11.4systemx86_64, darwin17.0uiRStudio
language (EN)
collateen_US.UTF-8ctypeen_US.UTF-8tzAmerica/New_Yorkdate2021-07-12
Acknowledgement
Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design
and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at:
http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
References
Vasanthakumar, A. et al. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease. Clin Epigenetics 12, 84 (2020).
Ellis, K.A. et al. Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study. Int Rev Psychiatry 25, 699-710 (2013).